Located in the heart of Europe and led by Anne Katrin Hilbert, Managing Director, the Marburg laboratory maintains a staff of approximately 90 employees in a 22,600 square foot space. The facility operates under BSL-2 and BSL-3, with an additional 750 sq. ft. dedicated to the handling of genetically modified organisms.

With more than 20 years of demonstrated expertise in selecting, developing, and validating immunological assays in support of vaccine development in both Novartis and GSK global environments, we provide cutting-edge expertise on tailored functional and immuno-binding serological assays for vaccine licensures.

We operate under GCLP using fit-for-purpose quality systems with a track record of success in authority lab inspections.

Equipment and Techniques

The following is a list of equipment and techniques performed on our infectious disease platform within our laboratory operations at our Marburg location.

  • Synbiosis ProtoCOL3
  • Microtechnix Scanlab II+CC
  • BioTek 405TS, ELx808 RMF, ELx405
  • ECHO Rebel
  • Scinomix SCI-PRINT VXL
  • Thermo Fisher Scientific KingFisher Duo Prime
  • TECAN Evo 75, Evo 100, Evo 200
  • TECAN Infinite 200 Pro
  • Hamilton Microlab Star
  • Luminex Flexmap 3D
  • Logos Biosystems Luna II
  • Thermo MaxQ 4000